Teva Pharmaceutical Industries
TEVA
$16.71
Share price
0.48%
Change (1 day)
5.69%
Change (1 year)
Categories
Market capitalization of Teva Pharmaceutical Industries (TEVA)
Market cap: $19.40 Billion USD
As of July 2025 Teva Pharmaceutical Industries has a market cap of $19.40 Billion USD. This makes Teva Pharmaceutical Industries the world's 1075th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Teva Pharmaceutical Industries from 1996 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | $19.40 B | -24.78% |
| 2024 | $25.79 B | 117.76% |
| 2023 | $11.84 B | 16.97% |
| 2022 | $10.12 B | 14.65% |
| 2021 | $8.83 B | -15.15% |
| 2020 | $10.41 B | -3.5% |
| 2019 | $10.79 B | -36.4% |
| 2018 | $16.96 B | -11.96% |
| 2017 | $19.26 B | -47.63% |
| 2016 | $36.79 B | -37.82% |
| 2015 | $59.17 B | 21.84% |
| 2014 | $48.56 B | 43.72% |
| 2013 | $33.79 B | 6.11% |
| 2012 | $31.84 B | -10.63% |
| 2011 | $35.63 B | -23.83% |
| 2010 | $46.78 B | -5.94% |
| 2009 | $49.74 B | 31.48% |
| 2008 | $37.83 B | 0.74% |
| 2007 | $37.55 B | 52.38% |
| 2006 | $24.64 B | -11.38% |
| 2005 | $27.81 B | 48.59% |
| 2004 | $18.71 B | 18.87% |
| 2003 | $15.74 B | 57.68% |
| 2002 | $9.98 B | 26.5% |
| 2001 | $7.89 B | -15.75% |
| 2000 | $9.37 B | 109.09% |
| 1999 | $4.48 B | 76.86% |
| 1998 | $2.53 B | -13.89% |
| 1997 | $2.94 B | -5.17% |
| 1996 | $3.10 B |
End of Day market cap according to different sources
On Jul 8th, 2025 the market cap of Teva Pharmaceutical Industries was reported to be:
$19.09 Billion USD
$19.30 Billion USD
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $244.54 B | 1,160.20% | 🇨🇭 Switzerland |
 Sanofi SNY | $119.83 B | 517.52% | 🇫🇷 France |
 GlaxoSmithKline GSK | $78.92 B | 306.71% | 🇬🇧 UK |
 Pfizer PFE | $145.31 B | 648.86% | 🇺🇸 USA |
 Merck MRK | $210.19 B | 983.20% | 🇺🇸 USA |
 Dr. Reddy's Laboratories RDY | $12.43 B | -35.95% | 🇮🇳 India |
 AstraZeneca AZN | $219.57 B | 1,031.52% | 🇬🇧 UK |